6, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced results of a Phase 2, open label trial studying investigational compound venetoclax in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia
(CLL) and 17p deletion.
According to the report, The increase in the patient pool for chronic lymphocytic leukemia
is a major driver of the market.
This year, it is expected that there will be approximately 5,000 deaths from Chronic Lymphocytic Leukemia
in the United States.
Malignant lymphoma supervening in chronic lymphocytic leukemia
and related disorders.
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
Chronic lymphocytic leukemia
presenting as acute urinary retention due to leukemic infiltration of the prostate.
Today, the list of presumptive service-connected health problems caused by exposure to Agent Orange and other herbicides includes chloracne (a skin disease), Hodgkin's disease, multiple myeloma (a cancer of the blood cells), non-Hodgkin's lymphoma, porphyria cutanea tarda (a skin disease caused by a defective liver enzyme), respiratory cancers (lung, bronchus, larynx, and trachea), soft-tissue sarcoma (cancer of the muscles and tendons), acute and subacute peripheral neuropathy (weakening of the nervous system), prostate cancer, chronic lymphocytic leukemia
, and adult-onset (Type 2) diabetes.
Results: CD4 and CD8 counts and CD4:CD8 ratios were normal in all eight patients, in contrast to the suppressor cell proliferation and low helper-suppressor ratios that have been previously reported in other patients with B-cell chronic lymphocytic leukemia
The patient was a 61-year-old woman with a 10-year history of chronic lymphocytic leukemia
Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia
Jones took a medical leave in December when it became apparent that he needed the transplant - the last option for chronic lymphocytic leukemia
, in which malignant cells accumulate because they do not die.
com/research/7q2jxf/bcell_chronic) has announced the addition of Global Markets Direct's new report "B-Cell Chronic Lymphocytic Leukemia
- Pipeline Review, H2 2012" to their offering.